1.A Case of Endometriosis in the Abdominal Subcutaneous Tissue.
Hyun Ju MOON ; Tae Gyu AHN ; Kyung LEE ; Hyoung Gyun ROH ; Sang Joon CHOI ; Chang Hoon SONG ; Hyuk JUNG
Korean Journal of Obstetrics and Gynecology 1999;42(3):641-645
the ineidence of abdominal subcutaneous endometriosis is quite rare we have experienced one case of subcutaneous endometriosis. The typical clinical bistory and local findings of endometriasis enabk us to make the conect diagnosis. the treatment of choice is complete surgical excision of endometrial tissue and post operative medical therapy. This case was reported with a brief review of the comcemed literatures.
Diagnosis
;
Endometriosis*
;
Female
;
Subcutaneous Tissue*
2.The Effects of Glutathione on Human Cancer Cells before and after the Application of Cisplatin.
Young Shin CHO ; Hyoung Gyun ROH ; Tae Gyu AHN ; Sei Jun HAN
Korean Journal of Obstetrics and Gynecology 2004;47(1):161-165
OBJECTIVE: The purpose of this study is to determine the time-dependant effects of Glutathione on the Cisplatin-induced cytotoxicity of human cervical carcinoma cells. METHODS: Two human cervical carcinoma cells, SiHa (squamous cell carcinoma cell), and CaSki (epidermoid metastatic carcinoma cell) were cultivated with RPMI1640 media. Reduced glutathione (GSH) and 2-oxo 4-thiazolidine carboxylic acid (OTC) were added one hour before and after Cisplatin (2-50 micro M/ml) was applied. The cells were incubated an additional 24 hours and viable cells were examined using a 3-[4,5- dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay. RESULTS: The MTT reduction rate of cisplatin-treated cervical carcinoma cells was increased significantly by the addition of glutathione (5 mM) or OTC (5 mM) both one hour before and after Cisplatin. A difference between MTT reduction rates one hour before and after cisplatin were not observed in either GSH or OTC. CONCLUSION: These results suggest that GSH and OTC have a protective effect on cisplatin-induced toxicity, and that this effect is about the same whether the agents were applied before or after the Cisplatin.
Cisplatin*
;
Glutathione*
;
Humans*